USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Boston Scientific Medical Device Limited

USPTO PatentsView assignee record - 107 granted patents across 22 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

107

Total patents granted

CPC technology areas

16.8

Avg claims per patent

5-year filing velocity

The verdict

Boston holds 107 US patents across 22 technology areas, rank #3,447 of 50,000 tracked assignees.

#3,447
of 50,000 US assignees by volume: Top 2%
by Innovation Score (62.9/100): 16.8
avg claims per patent

Portfolio overview

Boston Scientific Medical Device Limited has been granted 107 US utility patents between 2022 and 2025, placing Boston Scientific Medical Device Limited at rank #3,447 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Boston Scientific Medical Device Limited is one of the more focused assignees in the PatentsView dataset. By volume, Boston sits between Amtran Technology Co., Ltd. (107 patents, rank #3,443) and Elbit Systems Ltd. (107 patents, rank #3,451) - the closest US assignees by grant volume. The composite Innovation Score of 62.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 107 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Boston Scientific Medical Device Limited's 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Boston Scientific Medical Device Limited against peers pursuing similar technology classes.

Amtran Technology

107
Aurora Labs

107
BCE

107
Bestop

107
Costa Del Mar

107
Cylance

107
Diebold Nixdorf I…

107
Elbit Systems

107
Boston Scientific… ◀

107

What this shows Boston holds 107 patents at rank #3,447, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Boston

By rank, the assignees closest to #3,447 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Boston's primary technology class.

Boston's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Boston Scientific Medical Device Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	4	3.7%
2023	14	13.1%
2024	48	44.9%
2025	41	38.3%

Which technologies does Boston Scientific Medical Device Limited patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 96

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 43

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 6

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 5

B29D - PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE 4

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 3

G05G - CONTROL DEVICES OR SYSTEMS INSOFAR AS CHARACTERISED BY MECHANICAL FEATURES ONLY 3

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 3

Y10S - TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS 1

B25G - HANDLES FOR HAND IMPLEMENTS 1

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Where it ranks

Overall rank by patents

#3,447

Across all tracked assignees

Innovation Score

62.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Boston Scientific Medical Device Limited hold?

Boston Scientific Medical Device Limited holds 107 US granted patents filed between 2022 and 2025, spanning 22 technology areas.

What is Boston Scientific Medical Device Limited's Innovation Score?

Boston Scientific Medical Device Limited has an Innovation Score of 62.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Boston Scientific Medical Device Limited focus on?

Boston Scientific Medical Device Limited's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 96 patents. The company has filed patents in 22 CPC subclasses total.

Is Boston Scientific Medical Device Limited's patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Boston Scientific Medical Device Limited.

What does claim depth mean for Boston Scientific Medical Device Limited's patents?

Boston Scientific Medical Device Limited's patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Boston Scientific Medical Device Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Boston's 107 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Boston ranks #3,447 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.